{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T20:30:18Z","timestamp":1773088218075,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["Grant NO. ZR2022MH016"],"award-info":[{"award-number":["Grant NO. ZR2022MH016"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["Grant NO. ZR2021QH043"],"award-info":[{"award-number":["Grant NO. ZR2021QH043"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10067-024-06936-1","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T22:01:40Z","timestamp":1710453700000},"page":"1635-1646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Phenotypes of patients with systemic sclerosis in the Chinese Han population: a cluster analysis"],"prefix":"10.1007","volume":"43","author":[{"given":"Yaqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinya","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baocheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suyan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4745","authenticated-orcid":false,"given":"Zhenzhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,15]]},"reference":[{"issue":"15","key":"6936_CR1","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/TCRM.S219024","volume":"13","author":"RG Argula","year":"2019","unstructured":"Argula RG, Ward C, Feghali-Bostwick C (2019) Therapeutic challenges and advances in the management of systemic sclerosis-related pulmonary arterial hypertension (SSc-PAH). Ther Clin Risk Manag 13(15):1427\u20131442. https:\/\/doi.org\/10.2147\/TCRM.S219024","journal-title":"Ther Clin Risk Manag"},{"key":"6936_CR2","doi-asserted-by":"publisher","first-page":"969383","DOI":"10.1155\/2010\/969383","volume":"2010","author":"PX Coral-Alvarado","year":"2010","unstructured":"Coral-Alvarado PX, Garces MF, Caminos JE, Iglesias-Gamarra A, Restrepo JF, Quintana G (2010) Serum endoglin levels in patients suffering from systemic sclerosis and elevated systolic pulmonary arterial pressure. Int J Rheumatol 2010:969383. https:\/\/doi.org\/10.1155\/2010\/969383","journal-title":"Int J Rheumatol"},{"issue":"3","key":"6936_CR3","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.autrev.2014.11.002","volume":"14","author":"G Valentini","year":"2015","unstructured":"Valentini G (2015) Undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (so far referred to as very early\/early SSc or pre-SSc). Autoimmun Rev 14(3):210\u2013213. https:\/\/doi.org\/10.1016\/j.autrev.2014.11.002","journal-title":"Autoimmun Rev"},{"key":"6936_CR4","unstructured":"Adigun R, Goyal A, Hariz A (2023) Systemic sclerosis. 2022 May 8. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing"},{"issue":"5","key":"6936_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3390\/diagnostics12051067","volume":"12","author":"A Tieu","year":"2022","unstructured":"Tieu A, Chaigne B, Dunogu\u00e9 B et al (2022) Autoantibodies versus skin fibrosis extent in systemic sclerosis: a case-control study of inverted phenotypes. Diagnostics (Basel) 12(5):1067. https:\/\/doi.org\/10.3390\/diagnostics12051067","journal-title":"Diagnostics (Basel)"},{"issue":"2","key":"6936_CR6","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15(2):202\u2013205","journal-title":"J Rheumatol"},{"key":"6936_CR7","doi-asserted-by":"publisher","unstructured":"Medsger TA Jr (2003) Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 29(2):255\u201373, vi. https:\/\/doi.org\/10.1016\/s0889-857x(03)00023-1","DOI":"10.1016\/s0889-857x(03)00023-1"},{"issue":"7","key":"6936_CR8","first-page":"1528","volume":"34","author":"M Santiago","year":"2007","unstructured":"Santiago M, Baron M, Hudson M et al (2007) Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol 34(7):1528\u20131534","journal-title":"J Rheumatol"},{"issue":"12","key":"6936_CR9","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1093\/rheumatology\/keac188","volume":"61","author":"E Zanatta","year":"2022","unstructured":"Zanatta E, Huscher D, Ortolan A et al (2022) Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort. Rheumatology (Oxford) 61(12):4786\u20134796. https:\/\/doi.org\/10.1093\/rheumatology\/keac188","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"6936_CR10","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/art.40906","volume":"71","author":"V Sobanski","year":"2019","unstructured":"Sobanski V, Giovannelli J, Allanore Y et al (2019) Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis. Arthritis Rheumatol 71(9):1553\u20131570. https:\/\/doi.org\/10.1002\/art.40906","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"6936_CR11","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.semarthrit.2017.10.006","volume":"47","author":"BE Joven","year":"2018","unstructured":"Joven BE, Escribano P, Andreu JL et al (2018) 2013 ACR\/EULAR systemic sclerosis classification criteria in patients with associated pulmonary arterial hypertension. Semin Arthritis Rheum 47(6):870\u2013876. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.10.006","journal-title":"Semin Arthritis Rheum"},{"key":"6936_CR12","doi-asserted-by":"publisher","unstructured":"Humbert M, Kovacs G, Hoeper MM et al (2023) ESC\/ERS Scientific Document Group. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 6;61(1):2200879. https:\/\/doi.org\/10.1183\/13993003.00879-2022","DOI":"10.1183\/13993003.00879-2022"},{"issue":"10","key":"6936_CR13","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3899\/jrheum.101243","volume":"38","author":"M Hinchcliff","year":"2011","unstructured":"Hinchcliff M, Fischer A, Schiopu E, Steen VD, PHAROS Investigators (2011) Pulmonary hypertension assessment and recognition of outcomes in scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol 38(10):2172\u20139. https:\/\/doi.org\/10.3899\/jrheum.101243","journal-title":"J Rheumatol"},{"issue":"1","key":"6936_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200001000-00001","volume":"24","author":"AL Katzenstein","year":"2000","unstructured":"Katzenstein AL, Myers JL (2000) Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. Am J Surg Pathol 24(1):1\u20133. https:\/\/doi.org\/10.1097\/00000478-200001000-00001","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"6936_CR15","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12016-022-08945-x","volume":"64","author":"A Cole","year":"2023","unstructured":"Cole A, Ong VH, Denton CP (2023) Renal disease and systemic sclerosis: an update on scleroderma renal crisis. Clin Rev Allergy Immunol 64(3):378\u2013391. https:\/\/doi.org\/10.1007\/s12016-022-08945-x","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"6936_CR16","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.3389\/fimmu.2020.01990","volume":"4","author":"P Khedoe","year":"2020","unstructured":"Khedoe P, Marges E, Hiemstra P, Ninaber M, Geelhoed M (2020) Interstitial lung disease in patients with systemic sclerosis: toward personalized-medicine-based prediction and drug screening models of systemic sclerosis-related interstitial lung disease (SSc-ILD). Front Immunol 4(11):1990. https:\/\/doi.org\/10.3389\/fimmu.2020.01990","journal-title":"Front Immunol"},{"issue":"9","key":"6936_CR17","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.3389\/fimmu.2018.02045","volume":"7","author":"C Bruni","year":"2018","unstructured":"Bruni C, Frech T, Manetti M et al (2018) Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? Front Immunol 7(9):2045. https:\/\/doi.org\/10.3389\/fimmu.2018.02045","journal-title":"Front Immunol"},{"issue":"2","key":"6936_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1684\/abc.2020.1532","volume":"78","author":"A Tahiat","year":"2020","unstructured":"Tahiat A, Allam I, Abdessemed A et al (2020) Autoantibody profile in a cohort of Algerian patients with systemic sclerosis. Ann Biol Clin (Paris) 78(2):126\u2013133. https:\/\/doi.org\/10.1684\/abc.2020.1532","journal-title":"Ann Biol Clin (Paris)"},{"issue":"2","key":"6936_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0738-081x(94)90326-3","volume":"12","author":"MJ Goodfield","year":"1994","unstructured":"Goodfield MJ (1994) The skin in systemic sclerosis. Clin Dermatol 12(2):229\u201336. https:\/\/doi.org\/10.1016\/s0738-081x(94)90326-3","journal-title":"Clin Dermatol"},{"issue":"3","key":"6936_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4103\/0019-5154.96193","volume":"57","author":"SK Ghosh","year":"2012","unstructured":"Ghosh SK, Bandyopadhyay D, Saha I, Barua JK (2012) Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India. Indian J Dermatol 57(3):201\u2013205. https:\/\/doi.org\/10.4103\/0019-5154.96193","journal-title":"Indian J Dermatol"},{"issue":"10103","key":"6936_CR21","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet 390(10103):1685\u20131699. https:\/\/doi.org\/10.1016\/S0140-6736(17)30933-9","journal-title":"Lancet"},{"issue":"8","key":"6936_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J et al (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76(8):1327\u20131339. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"6936_CR23","doi-asserted-by":"publisher","first-page":"e31831","DOI":"10.7759\/cureus.31831","volume":"14","author":"F Galluccio","year":"2022","unstructured":"Galluccio F (2022) Rapid and sustained effect of ozone major autohemotherapy for Raynaud and hand edema in systemic sclerosis patient: a case report. Cureus 14(11):e31831. https:\/\/doi.org\/10.7759\/cureus.31831","journal-title":"Cureus"},{"issue":"8","key":"6936_CR24","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1136\/ard.2005.044602","volume":"65","author":"J Avouac","year":"2006","unstructured":"Avouac J, Guerini H, Wipff J et al (2006) Radiological hand involvement in systemic sclerosis. Ann Rheum Dis 65(8):1088\u20131092. https:\/\/doi.org\/10.1136\/ard.2005.044602","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6936_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/ajcp\/60.5.593","volume":"60","author":"HR Schumacher Jr","year":"1973","unstructured":"Schumacher HR Jr (1973) Joint involvement in progressive systemic sclerosis (scleroderma): a light and electron microscopic study of synovial membrane and fluid. Am J Clin Pathol 60(5):593\u2013600. https:\/\/doi.org\/10.1093\/ajcp\/60.5.593","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"6936_CR26","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1093\/rheumatology\/kes041","volume":"51","author":"J Avouac","year":"2012","unstructured":"Avouac J, Clements PJ, Khanna D, Furst DE, Allanore Y (2012) Articular involvement in systemic sclerosis. Rheumatology (Oxford) 51(8):1347\u20131356. https:\/\/doi.org\/10.1093\/rheumatology\/kes041","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6936_CR27","doi-asserted-by":"publisher","first-page":"1700889","DOI":"10.1183\/13993003.00889-2017","volume":"50","author":"A Boucly","year":"2017","unstructured":"Boucly A, Weatherald J, Savale L et al (2017) Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J 50(2):1700889. https:\/\/doi.org\/10.1183\/13993003.00889-2017","journal-title":"Eur Respir J"},{"issue":"9","key":"6936_CR28","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1164\/rccm.202105-1118OC","volume":"205","author":"CJ Rhodes","year":"2022","unstructured":"Rhodes CJ, Wharton J, Swietlik EM et al (2022) Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension. Am J Respir Crit Care Med 205(9):1102\u20131111. https:\/\/doi.org\/10.1164\/rccm.202105-1118OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"6936_CR29","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/s0954-6111(03)00254-3","volume":"97","author":"D Mukerjee","year":"2003","unstructured":"Mukerjee D, Yap LB, Holmes AM et al (2003) Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension. Respir Med 97(11):1230\u20131236. https:\/\/doi.org\/10.1016\/s0954-6111(03)00254-3","journal-title":"Respir Med"},{"issue":"3","key":"6936_CR30","doi-asserted-by":"publisher","first-page":"R143","DOI":"10.1186\/ar3876","volume":"14","author":"V Thakkar","year":"2012","unstructured":"Thakkar V, Stevens WM, Prior D et al (2012) N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Res Ther 14(3):R143. https:\/\/doi.org\/10.1186\/ar3876","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"6936_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1164\/ajrccm.160.2.9812078","volume":"160","author":"N Nagaya","year":"1999","unstructured":"Nagaya N, Uematsu M, Satoh T et al (1999) Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 160(2):487\u2013492. https:\/\/doi.org\/10.1164\/ajrccm.160.2.9812078","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Suppl 86","key":"6936_CR32","first-page":"S-214","volume":"32","author":"N Hansi","year":"2014","unstructured":"Hansi N, Thoua N, Carulli M et al (2014) Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis. Clin Exp Rheumatol 32(6 Suppl 86):S-214-21","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"6936_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00296-010-1595-y","volume":"32","author":"R Thonhofer","year":"2012","unstructured":"Thonhofer R, Siegel C, Trummer M, Graninger W (2012) Early endoscopy in systemic sclerosis without gastrointestinal symptoms. Rheumatol Int 32(1):165\u2013168. https:\/\/doi.org\/10.1007\/s00296-010-1595-y","journal-title":"Rheumatol Int"},{"issue":"10","key":"6936_CR34","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.cgh.2016.03.039","volume":"14","author":"DA Carlson","year":"2016","unstructured":"Carlson DA, Crowell MD, Kimmel JN et al (2016) Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis. Clin Gastroenterol Hepatol 14(10):1502\u20131506. https:\/\/doi.org\/10.1016\/j.cgh.2016.03.039","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6936_CR35","doi-asserted-by":"publisher","unstructured":"Katz PO, Gerson LB, Vela MF (2013) Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 108(3):308\u201328; quiz 329. https:\/\/doi.org\/10.1038\/ajg.2012.444. Erratum in: Am J Gastroenterol. 2013 Oct;108(10):1672.","DOI":"10.1038\/ajg.2012.444"},{"issue":"10","key":"6936_CR36","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1002\/1097-0142(19810515)47:10<2375::aid-cncr2820471009>3.0.co;2-i","volume":"47","author":"BF Smale","year":"1981","unstructured":"Smale BF, Mullen JL, Buzby GP, Rosato EF (1981) The efficacy of nutritional assessment and support in cancer surgery. Cancer 47(10):2375\u20132381. https:\/\/doi.org\/10.1002\/1097-0142(19810515)47:10%3c2375::aid-cncr2820471009%3e3.0.co;2-i","journal-title":"Cancer"},{"issue":"9","key":"6936_CR37","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G (1984) Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 85(9):1001\u20135 (Japanese)","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"5","key":"6936_CR38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.jgo.2020.03.013","volume":"11","author":"JB Cadwell","year":"2020","unstructured":"Cadwell JB, Afonso AM, Shahrokni A (2020) Prognostic nutritional index (PNI), independent of frailty is associated with six-month postoperative mortality. J Geriatr Oncol 11(5):880\u2013884. https:\/\/doi.org\/10.1016\/j.jgo.2020.03.013","journal-title":"J Geriatr Oncol"},{"issue":"6","key":"6936_CR39","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1080\/14397595.2019.1681653","volume":"30","author":"E Hasegawa","year":"2020","unstructured":"Hasegawa E, Kobayashi D, Kurosawa Y et al (2020) Nutritional status as the risk factor of serious infection in patients with rheumatoid arthritis. Mod Rheumatol 30(6):982\u2013989. https:\/\/doi.org\/10.1080\/14397595.2019.1681653","journal-title":"Mod Rheumatol"},{"issue":"8","key":"6936_CR40","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","volume":"47","author":"N Hunzelmann","year":"2008","unstructured":"Hunzelmann N, Genth E, Krieg T et al (2008) The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 47(8):1185\u20131192. https:\/\/doi.org\/10.1093\/rheumatology\/ken179","journal-title":"Rheumatology (Oxford)"},{"key":"6936_CR41","unstructured":"Adigun R, Goyal A, Hariz A (2023) Systemic sclerosis. 2022 May 8. In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing"},{"issue":"9","key":"6936_CR42","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/art.40906","volume":"71","author":"V Sobanski","year":"2019","unstructured":"Sobanski V, Giovannelli J, Allanore Y et al (2019) Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis. Arthritis Rheumatol 71(9):1553\u20131570. https:\/\/doi.org\/10.1002\/art.40906","journal-title":"Arthritis Rheumatol"},{"key":"6936_CR43","doi-asserted-by":"publisher","unstructured":"Srivastava N, Hudson M, Tatibouet S, et al; Canadian Scleroderma Research Group (CSRG) (2015) Thinking outside the box--the associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. Semin Arthritis Rheum 45(2):184\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.04.009.","DOI":"10.1016\/j.semarthrit.2015.04.009"},{"issue":"13","key":"6936_CR44","doi-asserted-by":"publisher","first-page":"1045523","DOI":"10.3389\/fimmu.2022.1045523","volume":"4","author":"J H\u00f6ppner","year":"2023","unstructured":"H\u00f6ppner J, Tabeling C, Casteleyn V et al (2023) Comprehensive autoantibody profiles in systemic sclerosis: clinical cluster analysis. Front Immunol 4(13):1045523. https:\/\/doi.org\/10.3389\/fimmu.2022.1045523","journal-title":"Front Immunol"},{"issue":"5","key":"6936_CR45","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/jid.2011.472","volume":"132","author":"SA Pendergrass","year":"2012","unstructured":"Pendergrass SA, Lemaire R, Francis IP et al (2012) Intrinsic gene expression subsets of diffuse cutaneous systemic sclerosis are stable in serial skin biopsies. J Invest Dermatol 132(5):1363\u20131373. https:\/\/doi.org\/10.1038\/jid.2011.472","journal-title":"J Invest Dermatol"},{"issue":"1","key":"6936_CR46","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1073\/pnas.1906593116","volume":"117","author":"P Gourh","year":"2020","unstructured":"Gourh P, Safran SA, Alexander T et al (2020) HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry. Proc Natl Acad Sci U S A 117(1):552\u2013562. https:\/\/doi.org\/10.1073\/pnas.1906593116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6936_CR47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.imlet.2018.03.011","volume":"198","author":"AT Dantas","year":"2018","unstructured":"Dantas AT, Almeida AR, Sampaio MCPD et al (2018) Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations. Immunol Lett 198:12\u201316. https:\/\/doi.org\/10.1016\/j.imlet.2018.03.011","journal-title":"Immunol Lett"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06936-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-06936-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-06936-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T01:13:56Z","timestamp":1713143636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-06936-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,15]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6936"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-06936-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3281711\/v1","asserted-by":"object"}]},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,15]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of Shandong Provincial Hospital, Shandong First Medical University (NSFC:NO.2022\u2013413). All participants signed the informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}